HF Sinclair Corporation Common Stock vs Immunovant Inc. Common Stock — how do they compare? HF Sinclair Corporation Common Stock trades at $120.4 (market cap $20.56B), while Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B). The key difference: HF Sinclair Corporation Common Stock is far larger — about 3.1× Immunovant Inc. Common Stock's market cap, and HF Sinclair Corporation Common Stock pays a 1.82% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold HF Sinclair Corporation Common Stock for 0 Days and Immunovant Inc. Common Stock for 0 Days on average.
| DINO | IMVT | |
|---|---|---|
Market Cap | $20.56B | $6.62B |
Volume | 2,204,425 | 1,131,364 |
Sector | Energy | Health |
52-Week High | $120.72 | $44.96 |
52-Week Low | $45.88 | $17.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $21.54B | $5.72B |
Dividend Yield | 1.82% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
HF Sinclair refines and markets petroleum products, including gasoline, diesel, and jet fuel. It also operates logistics and renewable fuels businesses.
Read more on DINO →Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →